PRNP and colorectal cancer: Accordingly, we documented that the PrPC-ILK module promotes the activation of YAP/TAZ [26], the two transcriptional effectors of the Hippo pathway, which play a key role in promoting the poor-prognosis mesenchymal subtype of colorectal cancer [28,45].